Roche Diagnostics Middle East

About Roche Diagnostics Middle East

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology & neuroscience. Roche is also the world leader in in-vitro diagnostics & tissue-based cancer diagnostics, &a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines & diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials & chemotherapy. In 2012, Roche took the unprecedented move of being the first IVD company to have a direct presence in the Middle East. Roche has extended its ownership of the entire supply chain, quality control and customer support all the way into the centre of the region. This base of operations reinforces the commitment to global Roche Standards and is driven by a full team of vastly experienced specialists offering a complete portfolio of services. With this regional empowerment, Roche has moved its leadership and decision-making closer to its customers and distributors. In addition to the establishment of a direct sales affiliate in Egypt to better meet the needs of the country's healthcare sector. These investments allow Roche become the preferred IVD partner for its customers.